Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy.

Abstract:

:Quantum dots (QDs) are luminescent nanocrystals with rich surface chemistry and unique optical properties that make them useful as probes or carriers for traceable targeted delivery and therapy applications. QDs can be functionalized to target specific cells or tissues by conjugating them with targeting ligands. Recent advancement in making biocompatible QD formulations has made these nanocrystals suitable for in vivo applications. This review provides an overview of the preparation of QDs and their use as probes or carriers for traceable, targeted therapy of diseases in vitro and in vivo. More specifically, recent advances in the integration of QDs with drug formulations for therapy and their potential toxicity in vitro and in vivo are highlighted. The current findings and challenges for optimizing QD/drug formulations with respect to optimal size and stability, short-term and long-term toxicity, and in vivo applications are described. Lastly, we attempt to predict key trends in QD/drug formulation development over the next few years and highlight areas of therapy where their use may provide breakthrough results in the near future.

journal_name

Theranostics

journal_title

Theranostics

authors

Yong KT,Wang Y,Roy I,Rui H,Swihart MT,Law WC,Kwak SK,Ye L,Liu J,Mahajan SD,Reynolds JL

doi

10.7150/thno.3692

subject

Has Abstract

pub_date

2012-01-01 00:00:00

pages

681-94

issue

7

issn

1838-7640

pii

thnov02p0681

journal_volume

2

pub_type

杂志文章
  • Supramolecular Assemblies of Peptides or Nucleopeptides for Gene Delivery.

    abstract::Using non-covalent interactions between nucleic acids (DNA, siRNA, miRNA, and mRNA) with peptides or nucleopeptides is a promising strategy to construct supramolecular assemblies for gene delivery and therapy. Comparing to conventional strategies for gene delivery, the assemblies of peptides or nucleopeptides provide ...

    journal_title:Theranostics

    pub_type: 杂志文章,评审

    doi:10.7150/thno.31854

    authors: Wang H,Feng Z,Xu B

    更新日期:2019-05-18 00:00:00

  • Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy.

    abstract::Photodynamic therapy (PDT) is an emerging theranostic modality for various cancers and diseases. The focus of this study was the development of tumor-targeting albumin nanoparticles containing photosensitizers for efficient PDT. To produce tumor-targeting albumin nanoparticles, the hydrophobic photosensitizer, chlorin...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno/v01p0230

    authors: Jeong H,Huh M,Lee SJ,Koo H,Kwon IC,Jeong SY,Kim K

    更新日期:2011-04-06 00:00:00

  • Lipid- and polymer-based nanostructures for cancer theranostics.

    abstract::The relatively new field of nanotheranostics combines the advantages of in vivo diagnosis with the ability to administer treatment through a single nano-sized carrier, offering new opportunities for cancer diagnosis and therapy. Nanotheranostics has facilitated the development of nanomedicine through direct visualizat...

    journal_title:Theranostics

    pub_type: 杂志文章,评审

    doi:10.7150/thno.4381

    authors: Luk BT,Fang RH,Zhang L

    更新日期:2012-01-01 00:00:00

  • Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs.

    abstract::Aplastic anemia (AA) is characterized as hypoplasia of bone marrow hematopoietic cells and hematopenia of peripheral blood cells. Though the supplement of exogenous erythropoietin (EPO) has been clinically approved for AA treatment, the side-effects hinder its further application. Here a robust treatment for AA induce...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.46794

    authors: Jia W,Zhen M,Li L,Zhou C,Sun Z,Liu S,Zhao Z,Li J,Wang C,Bai C

    更新日期:2020-05-23 00:00:00

  • Pretargeted molecular imaging and radioimmunotherapy.

    abstract::Pretargeting is a multi-step process that first has an unlabeled bispecific antibody (bsMAb) localize within a tumor by virtue of its anti-tumor binding site(s) before administering a small, fast-clearing radiolabeled compound that then attaches to the other portion of the bsMAb. The compound's rapid clearance signifi...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.3582

    authors: Goldenberg DM,Chang CH,Rossi EA,J W,McBride,Sharkey RM

    更新日期:2012-01-01 00:00:00

  • Circulating Tumor Cells: Moving Biological Insights into Detection.

    abstract::Circulating tumor cells (CTCs) have shown promising potential as liquid biopsies that facilitate early detection, prognosis, therapeutic target selection and monitoring treatment response. CTCs in most cancer patients are low in abundance and heterogeneous in morphological and phenotypic profiles, which complicate the...

    journal_title:Theranostics

    pub_type: 杂志文章,评审

    doi:10.7150/thno.18588

    authors: Chen L,Bode AM,Dong Z

    更新日期:2017-06-25 00:00:00

  • Mesenchymal Stromal/stem Cell-derived Extracellular Vesicles Promote Human Cartilage Regeneration In Vitro.

    abstract::Osteoarthritis (OA) is a rheumatic disease leading to chronic pain and disability with no effective treatment available. Recently, allogeneic human mesenchymal stromal/stem cells (MSC) entered clinical trials as a novel therapy for OA. Increasing evidence suggests that therapeutic efficacy of MSC depends on paracrine ...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.20746

    authors: Vonk LA,van Dooremalen SFJ,Liv N,Klumperman J,Coffer PJ,Saris DBF,Lorenowicz MJ

    更新日期:2018-01-01 00:00:00

  • A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity.

    abstract::A major challenge in photodynamic therapy (PDT) is the development of new tumor-targeting photosensitizers. The tumor-specific activation is considered to be an effective strategy for designing these photosensitizers. Herein, we describe a novel tumor-pH-responsive supramolecular photosensitizer, LDH-ZnPcS8, which is ...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.18861

    authors: Li X,Zheng BY,Ke MR,Zhang Y,Huang JD,Yoon J

    更新日期:2017-07-07 00:00:00

  • High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.

    abstract::Because of the unparalleled efficiency and universal utility in treating a variety of disease types, siRNA agents have evolved as the future drug-of-choice. Yet, the inability of the polyanionic siRNA macromolecules to cross the cell membrane remains as the bottleneck of possible clinical applications. With the cell p...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.19863

    authors: Ye J,Liu E,Gong J,Wang J,Huang Y,He H,Yang VC

    更新日期:2017-06-25 00:00:00

  • Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.

    abstract::Purpose: Positron emission tomography (PET) imaging of apoptosis is very important for early evaluation of tumor therapeutic efficacy. A stimuli-responsive probe based on the peptide sequence Asp-Glu-Val-Asp (DEVD), [18F]DEVD-Cys(StBu)-PPG(CBT)-AmBF3 ([18F]1), for PET imaging of tumor apoptosis was designed and prepar...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.35084

    authors: Qiu L,Wang W,Li K,Peng Y,Lv G,Liu Q,Gao F,Seimbille Y,Xie M,Lin J

    更新日期:2019-09-21 00:00:00

  • Fabrication of Red Blood Cell-Based Multimodal Theranostic Probes for Second Near-Infrared Window Fluorescence Imaging-Guided Tumor Surgery and Photodynamic Therapy.

    abstract::The therapeutic efficacy of fluorescence image-guided tumor surgery and photodynamic therapy (PDT) is impaired by the penetration depth limitation, low signal-to-noise ratio of traditional first near-infrared window (NIR I) fluorescence and the hypoxic tumor microenvironment. Here, a "red blood cell-based multimodal p...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.29817

    authors: Wang P,Wang X,Luo Q,Li Y,Lin X,Fan L,Zhang Y,Liu J,Liu X

    更新日期:2019-01-01 00:00:00

  • Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer.

    abstract::5-Fluorouracil (5-FU) combined with radiotherapy is a common treatment strategy to treat human cancers, but the underlying mechanisms of this combination treatment remain unclear. Here, we report that NAD+-dependent deacetylase sirtuin-7 (SIRT7) protein levels were decreased due to 5-FU exposure rendering colorectal c...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.18804

    authors: Tang M,Lu X,Zhang C,Du C,Cao L,Hou T,Li Z,Tu B,Cao Z,Li Y,Chen Y,Jiang L,Wang H,Wang L,Liu B,Xu X,Luo J,Wang J,Gu J,Wang H,Zhu WG

    更新日期:2017-03-22 00:00:00

  • Theranostic nanobubble encapsulating a plasmon-enhanced upconversion hybrid nanosystem for cancer therapy.

    abstract::Nanobubble (NB), which simultaneously enhances ultrasound (US) images and access therapeutic platforms, is required for future cancer treatment. Methods: We designed a theranostic agent for novel cancer treatment by using an NB-encapsulated hybrid nanosystem that can be monitored by US and fluorescent imaging and acti...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.38684

    authors: Huang WT,Chan MH,Chen X,Hsiao M,Liu RS

    更新日期:2020-01-01 00:00:00

  • Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo 18F-FDG-PET.

    abstract::Purpose: Cancer immunotherapy depends on a systemic immune response, but the basic underlying mechanisms are still largely unknown. Despite the very successful and widespread use of checkpoint inhibitors in the clinic, the majority of cancer patients do not benefit from this type of treatment. In this translational st...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.35989

    authors: Schwenck J,Schörg B,Fiz F,Sonanini D,Forschner A,Eigentler T,Weide B,Martella M,Gonzalez-Menendez I,Campi C,Sambuceti G,Seith F,Quintanilla-Martinez L,Garbe C,Pfannenberg C,Röcken M,la Fougere C,Pichler BJ,Kneilling M

    更新日期:2020-01-01 00:00:00

  • Drug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal route.

    abstract::Protein therapeutics is playing an increasingly critical role in treatment of human diseases. However, current vectors are captured by the digestive endo-lysosomal system, which results in an extremely low fraction (<2%) of protein being released in the cytoplasm. This paper reports a drug-delivering-drug platform (HA...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.23804

    authors: Xin X,Teng C,Du X,Lv Y,Xiao Q,Wu Y,He W,Yin L

    更新日期:2018-06-06 00:00:00

  • Theranostic potential of oncolytic vaccinia virus.

    abstract::Biological cancer therapies, such as oncolytic, or replication-selective viruses have advantages over traditional therapeutics as they can employ multiple different mechanisms to target and destroy cancers (including direct cell lysis, immune activation and vascular collapse). This has led to their rapid recent clinic...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.3724

    authors: Rojas JJ,Thorne SH

    更新日期:2012-01-01 00:00:00

  • A Microfluidic Platform for Single Cell Fluorometric Granzyme B Profiling.

    abstract::Granzyme B (GrB) is an essential cytotoxic effector in cancer immunotherapy as it can be a potential biomarker to predict the efficacy of immunotherapies including checkpoint inhibitors. Monitoring the Granzyme B activity in cells would help determine a patient's clinical response to treatment and lead to better treat...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.37728

    authors: Briones JC,Espulgar WV,Koyama S,Yoshikawa H,Park J,Naito Y,Kumanogoh A,Tamiya E,Takamatsu H,Saito M

    更新日期:2020-01-01 00:00:00

  • Recent Progress in Light-Triggered Nanotheranostics for Cancer Treatment.

    abstract::Treatments of high specificity are desirable for cancer therapy. Light-triggered nanotheranostics (LTN) mediated cancer therapy could be one such treatment, as they make it possible to visualize and treat the tumor specifically in a light-controlled manner with a single injection. Because of their great potential in c...

    journal_title:Theranostics

    pub_type: 杂志文章,评审

    doi:10.7150/thno.15217

    authors: Zhang P,Hu C,Ran W,Meng J,Yin Q,Li Y

    更新日期:2016-04-27 00:00:00

  • A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.

    abstract::The distorted and unique expression of microRNAs (miRNAs) in cancer makes them an attractive source of biomarker. There is much evidence indicating that a panel of miRNAs, termed "miRNA fingerprints", is more specific and informative than an individual miRNA as biomarker. Thus, multiplex assays for simultaneous quanti...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.19113

    authors: Xu F,Zhou W,Cao J,Xu Q,Jiang D,Chen Y

    更新日期:2017-07-08 00:00:00

  • In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats.

    abstract::Norepinephrine modulates cognitive processes such as working and episodic memory. Pathological changes in norepinephrine and norepinephrine transporter (NET) function and degeneration of the locus coeruleus produce irreversible impairments within the whole norepinephrine system, disrupting cognitive processes. Monitor...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.29740

    authors: López-Picón FR,Kirjavainen AK,Forsback S,Takkinen JS,Peters D,Haaparanta-Solin M,Solin O

    更新日期:2019-01-01 00:00:00

  • Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11-PET.

    abstract::Prostate-specific membrane antigen (PSMA) targeted PET has a high detection rate for biochemical recurrence (BCR) of prostate cancer (PCa). Nevertheless, even at high prostate-specific antigen (PSA) levels (> 3 ng/ml), a relevant number of PSMA-PET scans are negative, mainly due to PSMA-negative PCa. Our objective was...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.44584

    authors: Ferraro DA,Rüschoff JH,Muehlematter UJ,Kranzbühler B,Müller J,Messerli M,Husmann L,Hermanns T,Eberli D,Rupp NJ,Burger IA

    更新日期:2020-05-15 00:00:00

  • RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.

    abstract::Rationale: The overall success rate of prostate cancer (PCa) diagnosis and therapy has been improved over the years. However, genomic and phenotypic heterogeneity remains a major challenge for effective detection and treatment of PCa. Efforts to better classify PCa into functional subtypes and elucidate the molecular ...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.33292

    authors: Bai Y,Yang Y,Yan Y,Zhong J,Blee AM,Pan Y,Ma T,Karnes RJ,Jimenez R,Xu W,Huang H

    更新日期:2019-05-24 00:00:00

  • Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.

    abstract::Background: By targeting the prostate-specific membrane antigen (PSMA) on prostate cancer (PCa) cells PSMA-PET/CT shows great potential in locating the site of biochemical recurrence even at low PSA (Prostate-specific antigen)-levels. Accurate imaging of PCa recurrent lymph node metastases (LNM) is crucial for metasta...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.18421

    authors: Jilg CA,Drendel V,Rischke HC,Beck T,Vach W,Schaal K,Wetterauer U,Schultze-Seemann W,Meyer PT

    更新日期:2017-04-10 00:00:00

  • Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.

    abstract::Background: Metastasis is the major reason for high recurrence rates and poor survival among patients with colorectal cancer (CRC). However, the underlying molecular mechanism of CRC metastasis is unclear. This study aimed to investigate the role of forkhead box K2 (FOXK2), one of the most markedly increased FOX genes...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.31716

    authors: Du F,Qiao C,Li X,Chen Z,Liu H,Wu S,Hu S,Qiu Z,Qian M,Tian D,Wu K,Fan D,Nie Y,Xia L

    更新日期:2019-05-31 00:00:00

  • SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.

    abstract::SIRT6, NAD+-dependent deacetylase sirtuin 6, has recently shown to suppress tumor growth in several types of cancer. Colon cancer is a challenging carcinoma associated with high morbidity and death. However, whether SIRT6 play a direct role in colon tumorigenesis and the underlying mechanism are not understood. Method...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.29724

    authors: Zhang Y,Nie L,Xu K,Fu Y,Zhong J,Gu K,Zhang L

    更新日期:2019-04-13 00:00:00

  • Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer.

    abstract::Intrinsic and acquired resistance to targeted therapies is a significant clinical problem in cancer. We previously showed that resistance to regorafenib, a multi-kinase inhibitor for treating colorectal cancer (CRC) patients, can be caused by mutations in the tumor suppressor FBW7, which block degradation of the pro-s...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.45363

    authors: Song X,Shen L,Tong J,Kuang C,Zeng S,Schoen RE,Yu J,Pei H,Zhang L

    更新日期:2020-07-09 00:00:00

  • Establishing sheep as an experimental species to validate ultrasound-mediated blood-brain barrier opening for potential therapeutic interventions.

    abstract::Rationale: Treating diseases of the brain such as Alzheimer's disease (AD) is challenging as the blood-brain barrier (BBB) effectively restricts access of a large number of potentially useful drugs. A potential solution to this problem is presented by therapeutic ultrasound, a novel treatment modality that can achieve...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.22852

    authors: Pelekanos M,Leinenga G,Odabaee M,Odabaee M,Saifzadeh S,Steck R,Götz J

    更新日期:2018-04-03 00:00:00

  • Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells.

    abstract::Resistance to the chemotherapeutic drug 5'-azacytidine (5'-AZA) is a major obstacle in the treatment of patients with acute myeloid leukemia (AML). The uridine-cytidine kinase 1 (UCK1) has an established role in activating 5'-AZA and its protein level is significantly downregulated in patients resistant to the drug. H...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.36503

    authors: Zhang H,Huang H,Feng X,Song H,Zhang Z,Shen A,Qiu X

    更新日期:2020-01-01 00:00:00

  • TRPM8-regulated calcium mobilization plays a critical role in synergistic chemosensitization of Borneol on Doxorubicin.

    abstract::Background: Lung cancer has a high mortality rate and is resistant to multiple chemotherapeutics. Natural Borneol (NB) is a monoterpenoid compound that facilitates the bioavailability of drugs. In this study, we investigated the effects of NB on chemosensitivity in the A549 human lung adenocarcinoma cell line and to e...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.45861

    authors: Lai H,Liu C,Hou L,Lin W,Chen T,Hong A

    更新日期:2020-08-13 00:00:00

  • Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.

    abstract::To generate a more efficient in vivo reporter and therapeutic gene, we optimized the coding sequence of the human sodium/iodide symporter (NIS) gene by replacing NIS DNA codons from wild type to new codons having the highest usage in human gene translation. The Codon Adaptation Index (CAI), representing the number of ...

    journal_title:Theranostics

    pub_type: 杂志文章

    doi:10.7150/thno.10062

    authors: Kim YH,Youn H,Na J,Hong KJ,Kang KW,Lee DS,Chung JK

    更新日期:2015-01-01 00:00:00